Supplemental material
Expert Review of Vaccines
Volume 22, 2023 - Issue 1
Open access
1,456
Views
0
CrossRef citations to date
0
Altmetric
Original Research
Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany
Felicitas Kühnea Pfizer Pharma GmbH, Berlin, GermanyCorrespondence[email protected]
View further author information
, View further author information
Katharina Achtertb Private Institute for Applied Health Services Research (inav), Berlin, GermanyView further author information
, Franziska Püschnerb Private Institute for Applied Health Services Research (inav), Berlin, GermanyView further author information
, Dominika Urbanski-Rinib Private Institute for Applied Health Services Research (inav), Berlin, GermanyView further author information
, Juliane Schillerb Private Institute for Applied Health Services Research (inav), Berlin, GermanyView further author information
, Ernestine Mahara Pfizer Pharma GmbH, Berlin, GermanyView further author information
, Josephine Friedricha Pfizer Pharma GmbH, Berlin, GermanyView further author information
, Mark Atwoodc Policy Analysis Inc, Boston, Massachusetts, USAView further author information
, Ralf Sprengera Pfizer Pharma GmbH, Berlin, GermanyView further author information
, Jeffrey Vietrid Pfizer Inc, Collegeville, PA, USAView further author information
, Christof von Eiffa Pfizer Pharma GmbH, Berlin, GermanyView further author information
& Christian Theilackerd Pfizer Inc, Collegeville, PA, USAView further author information
show all
Pages 921-932
|
Received 24 Feb 2023, Accepted 20 Sep 2023, Published online: 27 Oct 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.